Art
J-GLOBAL ID:202202284829238951   Reference number:22A2899318

Measuring the Contrast Sensitivity Function in Non-Neovascular and Neovascular Age-Related Macular Degeneration: The Quantitative Contrast Sensitivity Function Test

非血管および血管新生加齢黄斑変性におけるコントラスト感度機能の測定:定量的コントラスト感度機能検査【JST・京大機械翻訳】
Author (7):
Material:
Volume: 10  Issue: 13  Page: 2768  Publication year: 2021 
JST Material Number: U7214A  ISSN: 2077-0383  Document type: Article
Article type: 文献レビュー  Country of issue: Switzerland (CHE)  Language: ENGLISH (EN)
Abstract/Point:
Abstract/Point
Japanese summary of the article(about several hundred characters).
All summary is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
Age-related macular degenerati...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=22A2899318&from=J-GLOBAL&jstjournalNo=U7214A") }}
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.

Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
, 【Automatic Indexing@JST】
JST classification (5):
JST classification
Category name(code) classified by JST.
Drug therapy(=pharmacotherapy)for eye diseases  ,  Basic research of drugs acting on sensory organs  ,  Visual sense  ,  Clinical application of drugs acting on sensory organs  ,  Treatment for eye diseases in general 
Reference (82):
  • Wong, W.L.; Su, X.; Li, X.; Cheung, C.M.; Klein, R.; Cheng, C.Y.; Wong, T.Y. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis. Lancet Glob. Health 2014, 2, e106-e116.
  • Colijn, J.M.; Buitendijk, G.H.S.; Prokofyeva, E.; Alves, D.; Cachulo, M.L.; Khawaja, A.P.; Cougnard-Gregoire, A.; Merle, B.M.; Korb, C.; Erke, M.G.; et al. Prevalence of Age-Related Macular Degeneration in Europe: The Past and the Future. Ophthalmology 2017, 124, 1753-1763.
  • Owsley, C.; Huisingh, C.; Clark, M.E.; Jackson, G.R.; McGwin, G. Comparison of visual function in older eyes in the earliest stages of age-related macular degeneration to those in normal macular health. Curr. Eye Res. 2016, 41, 266-272.
  • Sunness, J.S.; Rubin, G.S.; Broman, A.; Applegate, C.A.; Bressler, N.M.; Hawkins, B.S. Low luminance visual dysfunction as a predictor of subsequent visual acuity loss from geographic atrophy in age-related macular degeneration. Ophthalmology 2008, 115, 1480-1488.
  • Cocce, K.J.; Stinnett, S.S.; Luhmann, U.F.; Vajzovic, L.; Horne, A.; Schuman, S.G.; Toth, C.A.; Cousins, S.W.; Lad, E.M. Visual Function Metrics in Early and Intermediate Dry Age-related Macular Degeneration for Use as Clinical Trial Endpoints. Am. J. Ophthalmol. 2018, 189, 127-138.
more...

Return to Previous Page